Ananthakrishnan Ashwin N, Issa Mazen, Beaulieu Dawn B, Skaros Sue, Knox Josh F, Lemke Kathryn, Emmons Jeanne, Lundeen Sarah H, Otterson Mary F, Binion David G
Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Inflamm Bowel Dis. 2009 Feb;15(2):176-81. doi: 10.1002/ibd.20639.
Patients who require hospitalization for the management of ulcerative colitis (UC) may represent a subset with severe disease. These patients may be more likely to require future colectomy. There are limited data examining whether medical hospitalization is predictive of subsequent colectomy.
This was a retrospective case-control study utilizing the inflammatory bowel disease center database at our academic referral center. Cases comprised UC patients who underwent colectomy for disease refractory to medical management. The control population was comprised of all patients with UC who had not undergone colectomy. Multivariate logistic regression was used to identify independent predictors of requiring colectomy.
There were a total of 246 UC patients included in our study, with 103 being hospitalized sometime in their disease course (41.9%). A total of 27 patients underwent colectomy (11%). Colectomy patients were significantly more likely to have been on infliximab therapy (51.8% versus 22.4%, P = 0.001) but no more likely to have been on immunomodulator therapy (74.1% versus 59.4%, P = 0.14). Patients who required medical hospitalization for UC were more likely to require future colectomy (20.4% versus 4.2%, P < 0.001) than those who had not required hospitalization. On multivariate analysis, requiring medical hospitalization for management of UC (odds ratio [OR] 5.37, 95% confidence interval [CI] 2.00-14.46) and ever requiring infliximab therapy (OR 3.12, 95% CI 1.21-8.07) were independent predictors of colectomy.
Requiring medical hospitalization for the management of disease activity in UC is an independent predictor of the need for colectomy. Future studies will determine whether aggressive medical management may modify the need for colectomy in this cohort.
因溃疡性结肠炎(UC)住院治疗的患者可能是患有严重疾病的一个亚组。这些患者未来更有可能需要进行结肠切除术。关于内科住院治疗是否可预测后续结肠切除术的数据有限。
这是一项回顾性病例对照研究,利用我们学术转诊中心的炎症性肠病中心数据库。病例包括因药物治疗无效而接受结肠切除术的UC患者。对照人群由所有未接受结肠切除术的UC患者组成。采用多因素逻辑回归来确定需要进行结肠切除术的独立预测因素。
我们的研究共纳入246例UC患者,其中103例(41.9%)在病程中的某个时间点住院治疗。共有27例患者接受了结肠切除术(11%)。接受结肠切除术的患者使用英夫利昔单抗治疗的可能性显著更高(51.8%对22.4%,P = 0.001),但使用免疫调节剂治疗的可能性并无差异(74.1%对59.4%,P = 0.14)。因UC需要内科住院治疗的患者比未住院治疗的患者未来更有可能需要进行结肠切除术(20.4%对4.2%,P < 0.001)。多因素分析显示,因UC需要内科住院治疗(比值比[OR] 5.37, 95%置信区间[CI] 2.00 - 14.46)以及曾使用英夫利昔单抗治疗(OR 3.12, 95% CI 1.21 - 8.07)是结肠切除术的独立预测因素。
因UC疾病活动需要内科住院治疗是结肠切除术需求的独立预测因素。未来的研究将确定积极的内科治疗是否可改变该队列中结肠切除术的需求。